![William Demers](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Demers
Finanzdirektor/CFO bei POINT Biopharma, Inc. (United States)
Aktive Positionen von William Demers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POINT Biopharma, Inc. (United States)
![]() POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Finanzdirektor/CFO | 01.08.2020 | - |
Karriereverlauf von William Demers
Ehemalige bekannte Positionen von William Demers
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POIT BIOP | Finanzdirektor/CFO | 30.06.2021 | 27.12.2023 |
Unternehmenssekretär | - | 27.12.2023 | |
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.10.2014 | 01.06.2018 |
Ausbildung von William Demers
Wilfrid Laurier University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Kanada | 2 |
Operativ
Director of Finance/CFO | 4 |
Corporate Secretary | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POIT BIOP | Health Technology |
Private Unternehmen | 2 |
---|---|
Ernst & Young LLP
![]() Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
POINT Biopharma, Inc. (United States)
![]() POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Börse
- Insiders
- William Demers
- Erfahrung